A paper published by the National Bureau of Economic Research examines the economic impact of pharmacogenomic testing.
Read More
A study at the Public Library of Science finds that use of pharmacogenomics in managing drug regimens can help reduce readmissions and ER use.
Read More
The cost of whole genome sequencing is coming down, but cost, reproducibility, translation and process issues make its routine use for clinical practice unlikely without further refinement and knowledge growth.
Read More
An article in Nature describes a study of over 1000 individual genomes to identify variation. This is an important step in the continuing evolution of personalized medicine, which is proving…
Read More
Fall looms and brings the football season. Our Potpourri scores with nutritious bites of health information, including getting more genetic data into medical records, giving doctors price lists, the value…
Read More
The FDA issues a draft guidance on the use of clinical pharmacogenomics, in particular the gathering of relevant pharmacogenomic data in early drug development studies.
Read More
The year wears on, winter hopefully draws to a close, and our Potpourri provides nutritious sustenance, this week featuring comparative effectiveness research and personalized medicine, two surveys on hospital progress…
Read More
One interesting aspect of personalized medicine is the widespread ability of consumers to purchase somewhat inexpensive genome wide scanning for disease risk. New research evaluating the potential benefits or harms…
Read More
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.
Apple Podcasts
Google Podcasts
Spotify
Overcast
PocketCasts
Radio Public
Stitcher
Anchor
RSS - Posts